T-DM1 and the Dawn of Precision Medicine

Dr. Maurie Markman sees T-DM1, which combines antitumor activities of trastuzumab and HER2-targeted delivery of a cytotoxic agent, as an example of the precision medicine we can expect in the future.

Source: Medscape Pathology and Laboratory Medicine Podcast - March 20, 2013 Category: Laboratory Medicine Authors: Medscape Source Type: podcasts